Measurement of residual disease after neoadjuvant chemotherapy.

作者信息

Abrial Catherine, Thivat Emilie, Tacca Olivier, Durando Xavier, Mouret-Reynier Marie-Ange, Gimbergues Pierre, Penault-Llorca Frédérique, Chollet Philippe

出版信息

J Clin Oncol. 2008 Jun 20;26(18):3094; author reply 3095. doi: 10.1200/JCO.2008.16.7817.

DOI:10.1200/JCO.2008.16.7817

PMID:18565900

Abstract

摘要

相似文献

Measurement of residual disease after neoadjuvant chemotherapy.

J Clin Oncol. 2008 Jun 20;26(18):3094; author reply 3095. doi: 10.1200/JCO.2008.16.7817.

MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy.

Magn Reson Imaging Clin N Am. 2006 Aug;14(3):383-9, vii. doi: 10.1016/j.mric.2006.09.001.

Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.

J Clin Oncol. 2008 Jul 1;26(19):3286-8; author reply 3288. doi: 10.1200/JCO.2008.17.1116.

Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease.

Am J Surg Pathol. 2009 Feb;33(2):256-63. doi: 10.1097/PAS.0b013e31817fbdb4.

MRI in residual tumor size measurement in patient with breast cancer receiving neoadjuvant chemotherapy calls for caution.

Breast Cancer Res Treat. 2012 Aug;135(1):319-20. doi: 10.1007/s10549-012-2182-6. Epub 2012 Aug 1.

Tailoring loco-regional therapy with neoadjuvant chemotherapy: another step in the right direction.

Ann Surg Oncol. 2004 Oct;11(10):888-91. doi: 10.1245/ASO.2004.08.908. Epub 2004 Sep 20.

Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.

Breast Cancer Res Treat. 2009 Jul;116(1):153-60. doi: 10.1007/s10549-008-0160-9. Epub 2008 Sep 12.

Metformin as an addition to conventional chemotherapy in breast cancer.

J Clin Oncol. 2009 Dec 10;27(35):e259; author reply e260. doi: 10.1200/JCO.2009.25.4110. Epub 2009 Nov 2.

Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.

Anticancer Res. 2008 Sep-Oct;28(5B):3093-7.

Does Chemotherapy Induce Metastases?

Oncologist. 2018 Mar;23(3):273-274. doi: 10.1634/theoncologist.2017-0648.

引用本文的文献

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple-negative breast cancer.

Cancer Med. 2023 Mar;12(5):5846-5858. doi: 10.1002/cam4.5372. Epub 2022 Oct 21.

Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers.

NPJ Breast Cancer. 2022 May 10;8(1):64. doi: 10.1038/s41523-022-00427-9.

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer.

Drug Des Devel Ther. 2020 Jun 18;14:2423-2433. doi: 10.2147/DDDT.S253961. eCollection 2020.

Automatic cellularity assessment from post-treated breast surgical specimens.

Cytometry A. 2017 Nov;91(11):1078-1087. doi: 10.1002/cyto.a.23244. Epub 2017 Oct 4.

Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.

Mod Pathol. 2015 Jul;28(7):913-20. doi: 10.1038/modpathol.2015.53. Epub 2015 May 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验